• RV217 (ECHO): HIV - 1 Prevalence, Incidence, Cohort Retention, and Host Genetics and Viral Diversity in High Risk Cohorts in East Africa • Infectious Disease Surveillance (HIV,
TB and Malaria) and Cohort Development Among Urban and Rural Communities • Karolinska Institute
vaccine study in Tanzania testing a prime - boost HIV
vaccine regimen using unadjuvanted DNA
vaccines followed by a Modified Vaccinia Ankara (MVA), which was developed by MHRP and NIAID.